ARCHIVES

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

This article is from The Cancer Letter archive.

Vol. 18 No. 12 | March 20, 1992

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage

February 28, 2014

Young Scientists Get Their Share Of NCI Grants

March 29, 1974

An Alliance of NSABP-RTOG And GOG?

March 25, 2011

NCI Announces New Summer Training Awards

November 12, 1982

NCI Director Defends Goal to Eliminate Suffering, Death From Cancer by 2015

June 13, 2003